78 research outputs found

    Π‘ΠΊΡ€ΠΈΠ½ΠΈΠ½Π³ ΠΊΠ°Π»ΡŒΡ†ΠΈΠ½ΠΎΠ·Π° ΠΊΠΎΡ€ΠΎΠ½Π°Ρ€Π½Ρ‹Ρ… Π°Ρ€Ρ‚Π΅Ρ€ΠΈΠΉ ΠΌΠ΅Ρ‚ΠΎΠ΄ΠΎΠΌ ΠΌΡƒΠ»ΡŒΡ‚ΠΈΡΠΏΠΈΡ€Π°Π»ΡŒΠ½ΠΎΠΉ ΠΊΠΎΠΌΠΏΡŒΡŽΡ‚Π΅Ρ€Π½ΠΎΠΉ Ρ‚ΠΎΠΌΠΎΠ³Ρ€Π°Ρ„ΠΈΠΈ

    Get PDF
    Coronary atherosclerosis and coronary artery diseaseΒ (CAD) are theΒ  most common causes of death and disability inΒ the most ofΒ  industrialized countries. The problem of earlyΒ diagnosis of CADΒ  detection is extremely relevant all over theΒ world. PreclinicalΒ  identification of patients with risk factors ofΒ CAD is one of the mostΒ  important goal in routine clinical practice.Β Multislice computedΒ  tomography (MSCT) of the heartΒ with the determination of theΒ  calcium index (CI) is a noninvasiveΒ screening of coronary arteriesΒ  assessment. TheΒ severity of coronary calcification has a closeΒ  relationship withΒ the severity of coronary atherosclerosis and the risk of acuteΒ coronary events according to numerous studies. Initially,Β studies targeted on assessment of coronary calcification andΒ determination of normative parameters were performedΒ using electron-beam scanners (EBS). Subsequently multisliceΒ computed tomography (MSCT) replaced the electronicΒ beam tomography (EBCT). The results of studies thatΒ performed with EBS have become the basis for a methodologyΒ of coronary calcification assessment with MSCT. TheΒ reproducibility of coronary calcium score is important for assessment of atherosclerosis for dynamic monitoring. The inter- observer and intra-observer reproducibility of this method is quiteΒ  high, the reproducibility according to repeated studies of the sameΒ  patient is lower. In recent years, a new generation of volumetric CT- scanners has been introduced into clinical practice. Reducing the radiation dose for coronary calcium screening to the minimum values (less than 1 mSv) is one of the important advantages of volumetricΒ  computed tomography. Currently, new studies are needed to assessΒ  the reproducibility of coronary calcium index calculation using a newΒ  generation of volumetric CT-scanners.АтСросклСроз ΠΊΠΎΡ€ΠΎΠ½Π°Ρ€Π½Ρ‹Ρ… Π°Ρ€Ρ‚Π΅Ρ€ΠΈΠΉ ΠΈ ΠΈΡˆΠ΅ΠΌΠΈΡ‡Π΅ΡΠΊΠ°ΡΒ Π±ΠΎΠ»Π΅Π·Π½ΡŒ сСрдца (Π˜Π‘Π‘) ΡΠ²Π»ΡΡŽΡ‚ΡΡ Π½Π°ΠΈΠ±ΠΎΠ»Π΅Π΅ распространСнными ΠΏΡ€ΠΈΡ‡ΠΈΠ½Π°ΠΌΠΈ смСрти ΠΈ ΠΈΠ½Π²Π°Π»ΠΈΠ΄ΠΈΠ·Π°Ρ†ΠΈΠΈ Π² Π±ΠΎΠ»ΡŒΡˆΠΈΠ½ΡΡ‚Π²Π΅ ΠΈΠ½Π΄ΡƒΡΡ‚Ρ€ΠΈΠ°Π»ΡŒΠ½ΠΎ Ρ€Π°Π·Π²ΠΈΡ‚Ρ‹Ρ… стран ΠΌΠΈΡ€Π°. ΠŸΡ€ΠΎΠ±Π»Π΅ΠΌΠ°Β Ρ€Π°Π½Π½Π΅ΠΉ своСврСмСнной диагностики Π˜Π‘Π‘ ΠΊΡ€Π°ΠΉΠ½Π΅ Π°ΠΊΡ‚ΡƒΠ°Π»ΡŒΠ½Π° Π²ΠΎ всСм ΠΌΠΈΡ€Π΅. ДоклиничСскоС выявлСниС ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚ΠΎΠ² с Ρ„Π°ΠΊΡ‚ΠΎΡ€Π°ΠΌΠΈ риска развития Π˜Π‘Π‘ являСтся ΠΎΠ΄Π½ΠΎΠΉ ΠΈΠ·Β Π²Π°ΠΆΠ½Π΅ΠΉΡˆΠΈΡ… Π·Π°Π΄Π°Ρ‡ Π² Ρ€ΡƒΡ‚ΠΈΠ½Π½ΠΎΠΉ клиничСской ΠΏΡ€Π°ΠΊΡ‚ΠΈΠΊΠ΅. НСинвазивным скрининговым ΠΌΠ΅Ρ‚ΠΎΠ΄ΠΎΠΌ обслСдования коронарных Π°Ρ€Ρ‚Π΅Ρ€ΠΈΠΉ являСтся ΠΌΡƒΠ»ΡŒΡ‚ΠΈΡΠΏΠΈΡ€Π°Π»ΡŒΠ½Π°Ρ ΠΊΠΎΠΌΠΏΡŒΡŽΡ‚Π΅Ρ€Π½Π°Ρ томография (МБКВ) сСрдца с ΠΎΠΏΡ€Π΅Π΄Π΅Π»Π΅Π½ΠΈΠ΅ΠΌΒ ΠΊΠ°Π»ΡŒΡ†ΠΈΠ΅Π²ΠΎΠ³ΠΎ индСкса. По Π΄Π°Π½Π½Ρ‹ΠΌ многочислСнных исслСдований Π²Ρ‹Ρ€Π°ΠΆΠ΅Π½Π½ΠΎΡΡ‚ΡŒ ΠΊΠ°Π»ΡŒΡ†ΠΈΠ½ΠΎΠ·Π° ΠΊΠΎΡ€ΠΎΠ½Π°Ρ€Π½Ρ‹Ρ…Β Π°Ρ€Ρ‚Π΅Ρ€ΠΈΠΉ ΠΈΠΌΠ΅Π΅Ρ‚ Ρ‚Π΅ΡΠ½ΡƒΡŽ связь с Ρ‚ΡΠΆΠ΅ΡΡ‚ΡŒΡŽ атСросклСроза коронарных Π°Ρ€Ρ‚Π΅Ρ€ΠΈΠΉ ΠΈ риском развития коронарных событий. ΠŸΠ΅Ρ€Π²ΠΎΠ½Π°Ρ‡Π°Π»ΡŒΠ½ΠΎ исслСдования ΠΏΠΎ ΠΎΡ†Π΅Π½ΠΊΠ΅ ΠΊΠ°Π»ΡŒΡ†ΠΈΠ½ΠΎΠ·Π° ΠΊΠΎΡ€ΠΎΠ½Π°Ρ€Π½Ρ‹Ρ… Π°Ρ€Ρ‚Π΅Ρ€ΠΈΠΉ ΠΈ ΠΎΠΏΡ€Π΅Π΄Π΅Π»Π΅Π½ΠΈΡŽ Π½ΠΎΡ€ΠΌΠ°Ρ‚ΠΈΠ²Π½Ρ‹Ρ… ΠΏΠΎΠΊΠ°Π·Π°Ρ‚Π΅Π»Π΅ΠΉ Π±Ρ‹Π»ΠΈ Π²Ρ‹ΠΏΠΎΠ»Π½Π΅Π½Ρ‹ с ΠΈΡΠΏΠΎΠ»ΡŒΠ·ΠΎΠ²Π°Π½ΠΈΠ΅ΠΌΒ ΡΠ»Π΅ΠΊΡ‚Ρ€ΠΎΠ½Π½ΠΎ-Π»ΡƒΡ‡Π΅Π²Ρ‹Ρ… Ρ‚ΠΎΠΌΠΎΠ³Ρ€Π°Ρ„ΠΎΠ². ПозТС МБКВ Π·Π°ΠΌΠ΅Π½ΠΈΠ»Π° элСктронно-Π»ΡƒΡ‡Π΅Π²ΡƒΡŽ Ρ‚ΠΎΠΌΠΎΠ³Ρ€Π°Ρ„ΠΈΡŽ. Π Π΅Π·ΡƒΠ»ΡŒΡ‚Π°Ρ‚Ρ‹ исслСдований, Π²Ρ‹ΠΏΠΎΠ»Π½Π΅Π½Π½Ρ‹Ρ… с ΠΏΠΎΠΌΠΎΡ‰ΡŒΡŽ элСктронно- Π»ΡƒΡ‡Π΅Π²Ρ‹Ρ…Β Ρ‚ΠΎΠΌΠΎΠ³Ρ€Π°Ρ„ΠΎΠ², стали основой для Ρ€Π°Π·Ρ€Π°Π±ΠΎΡ‚ΠΊΠΈ ΠΌΠ΅Ρ‚ΠΎΠ΄ΠΈΠΊΠΈΒ ΠΎΡ†Π΅Π½ΠΊΠΈ ΠΊΠ°Π»ΡŒΡ†ΠΈΠ½ΠΎΠ·Π°Β  ΠΊΠΎΡ€ΠΎΠ½Π°Ρ€Π½Ρ‹Ρ… Π°Ρ€Ρ‚Π΅Ρ€ΠΈΠΉ с использованиСм МБКВ. Π’ΠΎΡΠΏΡ€ΠΎΠΈΠ·Π²ΠΎΠ΄ΠΈΠΌΠΎΡΡ‚ΡŒ Ρ€Π΅Π·ΡƒΠ»ΡŒΡ‚Π°Ρ‚ΠΎΠ² подсчСта коронарного ΠΊΠ°Π»ΡŒΡ†ΠΈΠ΅Π²ΠΎΠ³ΠΎ индСкса Π²Π°ΠΆΠ½Π° для оцСнки тСчСния атСросклСроза. ΠŸΡ€ΠΈΒ  использовании ΠœΠ‘ΠšΠ’Β ΠΌΠ΅ΠΆΠΎΠΏΠ΅Ρ€Π°Ρ‚ΠΎΡ€ΡΠΊΠ°Ρ ΠΈ внутриопСраторская Π²ΠΎΡΠΏΡ€ΠΎΠΈΠ·Π²ΠΎΠ΄ΠΈΠΌΠΎΡΡ‚ΡŒΒ  достаточно высоки, ΠΏΡ€ΠΈ ΠΏΠΎΠ²Ρ‚ΠΎΡ€Π½Ρ‹Ρ… исслСдованиях Ρƒ ΠΎΠ΄Π½ΠΎΠ³ΠΎ ΠΈ Ρ‚ΠΎΠ³ΠΎ ΠΆΠ΅ ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚Π°Β  Π²ΠΎΡΠΏΡ€ΠΎΠΈΠ·Π²ΠΎΠ΄ΠΈΠΌΠΎΡΡ‚ΡŒΒ ΠΌΠ΅Ρ‚ΠΎΠ΄Π° Π½ΠΈΠΆΠ΅. Π’ послСдниС Π³ΠΎΠ΄Ρ‹ Π² ΠΊΠ»ΠΈΠ½ΠΈΡ‡Π΅ΡΠΊΡƒΡŽ ΠΏΡ€Π°ΠΊΡ‚ΠΈΠΊΡƒΒ Π±Ρ‹Π»ΠΎ Π²Π½Π΅Π΄Ρ€Π΅Π½ΠΎΒ  Π½ΠΎΠ²ΠΎΠ΅ ΠΏΠΎΠΊΠΎΠ»Π΅Π½ΠΈΠ΅ ΡˆΠΈΡ€ΠΎΠΊΠΎΠ΄Π΅Ρ‚Π΅ΠΊΡ‚ΠΎΡ€Π½Ρ‹Ρ…Β ΠΎΠ±ΡŠΠ΅ΠΌΠ½Ρ‹Ρ… ΠΊΠΎΠΌΠΏΡŒΡŽΡ‚Π΅Ρ€Π½Ρ‹Ρ… Ρ‚ΠΎΠΌΠΎΠ³Ρ€Π°Ρ„ΠΎΠ². Π‘Π½ΠΈΠΆΠ΅Π½ΠΈΠ΅ Π»ΡƒΡ‡Π΅Π²ΠΎΠΉ Π½Π°Π³Ρ€ΡƒΠ·ΠΊΠΈ Π΄ΠΎ ΠΌΠΈΠ½ΠΈΠΌΠ°Π»ΡŒΠ½Ρ‹Ρ… Π·Π½Π°Ρ‡Π΅Π½ΠΈΠΉ ΠΏΡ€ΠΈ провСдСнии скрининга ΠΊΠ°Π»ΡŒΡ†ΠΈΠ½ΠΎΠ·Π°Β  ΠΊΠΎΡ€ΠΎΠ½Π°Ρ€Π½Ρ‹Ρ… Π°Ρ€Ρ‚Π΅Ρ€ΠΈΠΉ являСтся одним ΠΈΠ· Π²Π°ΠΆΠ½Ρ‹Ρ… прСимущСств ΠΎΠ±ΡŠΠ΅ΠΌΠ½Ρ‹Ρ… ΠΊΠΎΠΌΠΏΡŒΡŽΡ‚Π΅Ρ€Π½Ρ‹Ρ…Β  Ρ‚ΠΎΠΌΠΎΠ³Ρ€Π°Ρ„ΠΎΠ². Π’ настоящСС врСмя Π½Π΅ΠΎΠ±Ρ…ΠΎΠ΄ΠΈΠΌΠΎ ΠΏΡ€ΠΎΠ²Π΅Π΄Π΅Π½ΠΈΠ΅ исслСдований ΠΏΠΎ ΠΎΡ†Π΅Π½ΠΊΠ΅ воспроизводимости подсчСта ΠΊΠΎΡ€ΠΎΠ½Π°Ρ€Π½ΠΎΠ³ΠΎ ΠΊΠ°Π»ΡŒΡ†ΠΈΠ΅Π²ΠΎΠ³ΠΎ индСкса ΠΏΡ€ΠΈ использовании Π½ΠΎΠ²ΠΎΠ³ΠΎ поколСния ΠΊΠΎΠΌΠΏΡŒΡŽΡ‚Π΅Ρ€Π½Ρ‹Ρ… Ρ‚ΠΎΠΌΠΎΠ³Ρ€Π°Ρ„ΠΎΠ²

    ЛУЧЕВАЯ Π”Π˜ΠΠ“ΠΠžΠ‘Π’Π˜ΠšΠ ΠŸΠΠ’ΠžΠ›ΠžΠ“Π˜Π™ ΠŸΠΠ’Π•Π›Π›ΠžΠ€Π•ΠœΠžΠ ΠΠ›Π¬ΠΠžΠ“Πž Π‘ΠžΠ§Π›Π•ΠΠ•ΠΠ˜Π―

    Get PDF
    The problem of diagnosis and treatment of diseases of the patellofemoral joint (PFJ) remains relevant currently, since joint damage affects mainly young employable patients. The review analyzes the data of foreign and domestic literature on methods of the visualization of pathological conditions of patellofemoral articulation. Analysis of the literature has shown that now there is no single algorithm for detecting the pathology of PFJ by radiological methods, especially on early stages, when the effectiveness of treatment is the highest.Π’ настоящСС врСмя ΠΏΡ€ΠΎΠ±Π»Π΅ΠΌΠ° диагностики ΠΈ лСчСния Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΠΉ ΠΏΠ°Ρ‚Π΅Π»Π»ΠΎΡ„Π΅ΠΌΠΎΡ€Π°Π»ΡŒΠ½ΠΎΠ³ΠΎ сочлСнСния (ПЀБ) сохраняСт свою Π°ΠΊΡ‚ΡƒΠ°Π»ΡŒΠ½ΠΎΡΡ‚ΡŒ, Ρ‚Π°ΠΊ ΠΊΠ°ΠΊ ΠΏΠΎΡ€Π°ΠΆΠ΅Π½ΠΈΠ΅ сустава Π·Π°Ρ‚Ρ€Π°Π³ΠΈΠ²Π°Π΅Ρ‚ Π² основном ΠΌΠΎΠ»ΠΎΠ΄Ρ‹Ρ… трудоспособных ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚ΠΎΠ². Π’ ΠΎΠ±Π·ΠΎΡ€Π΅ ΠΏΡ€ΠΎΠ°Π½Π°Π»ΠΈΠ·ΠΈΡ€ΠΎΠ²Π°Π½Ρ‹ Π΄Π°Π½Π½Ρ‹Π΅ Π·Π°Ρ€ΡƒΠ±Π΅ΠΆΠ½ΠΎΠΉ ΠΈ отСчСствСнной Π»ΠΈΡ‚Π΅Ρ€Π°Ρ‚ΡƒΡ€Ρ‹, посвящСнныС ΠΌΠ΅Ρ‚ΠΎΠ΄Π°ΠΌ Π»ΡƒΡ‡Π΅Π²ΠΎΠΉ диагностики патологичСских состояний ПЀБ. Анализ Π»ΠΈΡ‚Π΅Ρ€Π°Ρ‚ΡƒΡ€Ρ‹ ΠΏΠΎΠΊΠ°Π·Π°Π», Ρ‡Ρ‚ΠΎ Π² настоящСС врСмя Π½Π΅Ρ‚ Π΅Π΄ΠΈΠ½ΠΎΠ³ΠΎ Π°Π»Π³ΠΎΡ€ΠΈΡ‚ΠΌΠ° выявлСния ΠΏΠ°Ρ‚ΠΎΠ»ΠΎΠ³ΠΈΠΈ ПЀБ ΠΌΠ΅Ρ‚ΠΎΠ΄Π°ΠΌΠΈ Π»ΡƒΡ‡Π΅Π²ΠΎΠΉ диагностики, особСнно Π½Π° Ρ€Π°Π½Π½ΠΈΡ… стадиях, ΠΊΠΎΠ³Π΄Π° ΡΡ„Ρ„Π΅ΠΊΡ‚ΠΈΠ²Π½ΠΎΡΡ‚ΡŒ лСчСния самая высокая

    ВозмоТности соврСмСнных ΠΌΠ΅Ρ‚ΠΎΠ΄ΠΎΠ² Π»ΡƒΡ‡Π΅Π²ΠΎΠΉ диагностики Π² ΠΎΠΏΡ€Π΅Π΄Π΅Π»Π΅Π½ΠΈΠΈ ΠΈ ΠΏΡ€Π΅Π΄ΠΎΠΏΠ΅Ρ€Π°Ρ†ΠΈΠΎΠ½Π½ΠΎΠΌ ΠΏΠ»Π°Π½ΠΈΡ€ΠΎΠ²Π°Π½ΠΈΠΈ ΠΊΠΎΠ°Ρ€ΠΊΡ‚Π°Ρ†ΠΈΠΈ Π°ΠΎΡ€Ρ‚Ρ‹ Ρƒ Π΄Π΅Ρ‚Π΅ΠΉ Π΄ΠΎ Π³ΠΎΠ΄Π° ΠΈ младшСй возрастной Π³Ρ€ΡƒΠΏΠΏΡ‹

    Get PDF
    Objective. Evaluation of diagnostic value of modern imaging modalities: trans-thoracic echocardiography (TTE), CT-angiography (CTA) and cardio-MRI in diagnosis and preoperative planning of aortic coarctation correction (CoA) in in infants and young age group children.Materials and methods. 101 pediatric patients (aged 0 to 5 years) with CoA underwent TTE, 98 of them underwent CT, 30 – cardio MRI. On TTE, CTA and cardio-MRI aorta morphometry was performed. The most common anomalies associated with CoA (ventricular septal defect (VSD), patent ductus arteriosus (PDA), aberrant right subclavian artery (ARSA), hypoplastic arch and brachiocephalic vessels anomalies) were assessed.Results. The overall diagnostic accuracy of TTE, CT and cardiac-MRI in diagnosis of CoA were 89.1%, 95.9%, 86.7% respectively. There was no significant difference in the accuracy in detecting CoA between TTE, CT and MRI (p > 0.05). The accuracy of TTE in determining the brachiocephalic vessels anomalies, ARSA and arch hypoplasia was 84%, 93% and 85.3%, respectively. The accuracy of CT in determining the brachiocephalic vessels anomalies, ARSA and arch hypoplasia was 100%, 100% and 98% and cardio-MRI: 97.1%, 98.4% and 96.8%, respectively.Conclusion. TTE is a widely available and safe method, it has a high diagnostic value in determining CoA. Due to limitations in visualization of all parts of the aortic arch and the detection of concomitant anomalies, TTE cannot be the final method in planning the CoA correction. CT and MRI of the heart, as a TTE, are effective methods in the diagnosis of CoA, however, in the assessment of extracardiac anomalies, they equally show a significantly more accurate result.Taking into account the difficulties in conducting MRI of the heart in children under one year and younger age group, the need for a longer stay in anesthesia, the lack of additional diagnostically significant information in comparison with CT of the heart, cardio-MRI is not the method of choice in the primary diagnosis and preoperative planning of correction of CoA in children under one year and younger age group requiring the use of an anesthetic aid for the duration of the scan. Cardio-MRI may be the method of choice in preoperative planning of CoA in small children with absolute contraindications to the radiocontrast agent.ЦСль исслСдования: ΠΎΡ†Π΅Π½ΠΈΡ‚ΡŒ Π΄ΠΈΠ°Π³Π½ΠΎΡΡ‚ΠΈΡ‡Π΅ΡΠΊΡƒΡŽ ΡΡ„Ρ„Π΅ΠΊΡ‚ΠΈΠ²Π½ΠΎΡΡ‚ΡŒ соврСмСнных ΠΌΠ΅Ρ‚ΠΎΠ΄ΠΎΠ² диагностики: Π­Ρ…ΠΎΠšΠ“, КВ ΠΈ МРВ сСрдца Π² выявлСнии ΠΈ хирургичСском ΠΏΠ»Π°Π½ΠΈΡ€ΠΎΠ²Π°Π½ΠΈΠΈ ΠΊΠΎΡ€Ρ€Π΅ΠΊΡ†ΠΈΠΈ ΠΊΠΎΠ°Ρ€ΠΊΡ‚Π°Ρ†ΠΈΠΈ Π°ΠΎΡ€Ρ‚Ρ‹ (КоАо) Ρƒ Π΄Π΅Ρ‚Π΅ΠΉ Π΄ΠΎ Π³ΠΎΠ΄Π° ΠΈ младшСй возрастной Π³Ρ€ΡƒΠΏΠΏΡ‹.ΠœΠ°Ρ‚Π΅Ρ€ΠΈΠ°Π» ΠΈ ΠΌΠ΅Ρ‚ΠΎΠ΄Ρ‹. Π’ исслСдованиС Π²ΠΊΠ»ΡŽΡ‡Π΅Π½ 101 Ρ€Π΅Π±Π΅Π½ΠΎΠΊ Π² возрастС ΠΎΡ‚ 0 Π΄ΠΎ 5 Π»Π΅Ρ‚. ВсСм дСтям ΠΏΡ€ΠΎΠ²Π΅Π΄Π΅Π½ΠΎ Π­Ρ…ΠΎΠšΠ“, 98 ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚Π°ΠΌ – КВ сСрдца, 30 – МРВ сСрдца. ΠŸΡ€ΠΈ ΠΈΠ½Ρ‚Π΅Ρ€ΠΏΡ€Π΅Ρ‚Π°Ρ†ΠΈΠΈ Ρ€Π΅Π·ΡƒΠ»ΡŒΡ‚Π°Ρ‚ΠΎΠ² Π­Ρ…ΠΎΠšΠ“, КВ ΠΈ МРВ сСрдца ΠΎΡΡƒΡ‰Π΅ΡΡ‚Π²Π»ΡΠ»ΠΈΡΡŒ Π°Π½Π°Π»ΠΈΠ· ΠΈ морфомСтрия всСх ΠΎΡ‚Π΄Π΅Π»ΠΎΠ² Π°ΠΎΡ€Ρ‚Ρ‹, ΠΏΡ€ΠΎΠ²ΠΎΠ΄ΠΈΠ»Π°ΡΡŒ ΠΎΡ†Π΅Π½ΠΊΠ° наличия ΡΠΎΠΏΡƒΡ‚ΡΡ‚Π²ΡƒΡŽΡ‰ΠΈΡ… Π°Π½ΠΎΠΌΠ°Π»ΠΈΠΉ: абСррантная правая ΠΏΠΎΠ΄ΠΊΠ»ΡŽΡ‡ΠΈΡ‡Π½Π°Ρ артСрия, ΡΠ΅ΠΏΡ‚Π°Π»ΡŒΠ½Ρ‹Π΅ Π΄Π΅Ρ„Π΅ΠΊΡ‚Ρ‹, ΠΎΡ‚ΠΊΡ€Ρ‹Ρ‚Ρ‹ΠΉ Π°Ρ€Ρ‚Π΅Ρ€ΠΈΠ°Π»ΡŒΠ½Ρ‹ΠΉ ΠΏΡ€ΠΎΡ‚ΠΎΠΊ, патология Π±Ρ€Π°Ρ…ΠΈΠΎΡ†Π΅Ρ„Π°Π»ΡŒΠ½Ρ‹Ρ… сосудов (Π‘Π¦Π‘) ΠΈ ΡΠΎΠΏΡƒΡ‚ΡΡ‚Π²ΡƒΡŽΡ‰Π°Ρ гипоплазия Π΄ΡƒΠ³ΠΈ Π°ΠΎΡ€Ρ‚Ρ‹.Π Π΅Π·ΡƒΠ»ΡŒΡ‚Π°Ρ‚Ρ‹. ДиагностичСская Ρ‚ΠΎΡ‡Π½ΠΎΡΡ‚ΡŒ Π­Ρ…ΠΎΠšΠ“, КВ ΠΈ МРВ сСрдца Π² ΠΎΠΏΡ€Π΅Π΄Π΅Π»Π΅Π½ΠΈΠΈ КоАо Ρƒ Π΄Π΅Ρ‚Π΅ΠΉ Π΄ΠΎ Π³ΠΎΠ΄Π° ΠΈ младшСй возрастной Π³Ρ€ΡƒΠΏΠΏΡ‹ составили 89,1, 95,9, 86,7% соотвСтствСнно. Π’ ΠΎΠΏΡ€Π΅Π΄Π΅Π»Π΅Π½ΠΈΠΈ ΠΏΠ°Ρ‚ΠΎΠ»ΠΎΠ³ΠΈΠΈ Π‘Π¦Π‘, Π°Π±Π΅Ρ€Ρ€Π°Π½Ρ‚Π½ΠΎΠΉ ΠΏΡ€Π°Π²ΠΎΠΉ ΠΏΠΎΠ΄ΠΊΠ»ΡŽΡ‡ΠΈΡ‡Π½ΠΎΠΉ Π°Ρ€Ρ‚Π΅Ρ€ΠΈΠΈ ΠΈ Π³ΠΈΠΏΠΎΠΏΠ»Π°Π·ΠΈΠΈ Π΄ΡƒΠ³ΠΈ Ρ‚ΠΎΡ‡Π½ΠΎΡΡ‚ΡŒ Π­Ρ…ΠΎΠšΠ“ составила 84, 93 ΠΈ 85,3% соотвСтствСнно. Π˜Π½Ρ„ΠΎΡ€ΠΌΠ°Ρ‚ΠΈΠ²Π½ΠΎΡΡ‚ΡŒ КВ Π² ΠΎΠΏΡ€Π΅Π΄Π΅Π»Π΅Π½ΠΈΠΈ ΠΏΠ°Ρ‚ΠΎΠ»ΠΎΠ³ΠΈΠΈ Π‘Π¦Π‘, Π°Π±Π΅Ρ€Ρ€Π°Π½Ρ‚Π½ΠΎΠΉ ΠΏΡ€Π°Π²ΠΎΠΉ ΠΏΠΎΠ΄ΠΊΠ»ΡŽΡ‡ΠΈΡ‡Π½ΠΎΠΉ Π°Ρ€Ρ‚Π΅Ρ€ΠΈΠΈ ΠΈ Π³ΠΈΠΏΠΎΠΏΠ»Π°Π·ΠΈΠΈ Π΄ΡƒΠ³ΠΈ составила 100, 100 ΠΈ 98% соотвСтствСнно. Π’ΠΎΡ‡Π½ΠΎΡΡ‚ΡŒ ΠΊΠ°Ρ€Π΄ΠΈΠΎ-МРВ Π² ΠΎΠΏΡ€Π΅Π΄Π΅Π»Π΅Π½ΠΈΠΈ ΠΏΠ°Ρ‚ΠΎΠ»ΠΎΠ³ΠΈΠΈ Π‘Π¦Π‘, Π°Π±Π΅Ρ€Ρ€Π°Π½Ρ‚Π½ΠΎΠΉ ΠΏΡ€Π°Π²ΠΎΠΉ ΠΏΠΎΠ΄ΠΊΠ»ΡŽΡ‡ΠΈΡ‡Π½ΠΎΠΉ Π°Ρ€Ρ‚Π΅Ρ€ΠΈΠΈ ΠΈ Π³ΠΈΠΏΠΎΠΏΠ»Π°Π·ΠΈΠΈ Π΄ΡƒΠ³ΠΈ составила 97,1, 98,4 ΠΈ 96,8% соотвСтствСнно.Π—Π°ΠΊΠ»ΡŽΡ‡Π΅Π½ΠΈΠ΅. Π­Ρ…ΠΎΠšΠ“, Π±ΡƒΠ΄ΡƒΡ‡ΠΈ ΡˆΠΈΡ€ΠΎΠΊΠΎΠ΄ΠΎΡΡ‚ΡƒΠΏΠ½Ρ‹ΠΌ ΠΈ бСзопасным ΠΌΠ΅Ρ‚ΠΎΠ΄ΠΎΠΌ, ΠΈΠΌΠ΅Π΅Ρ‚ Π²Ρ‹ΡΠΎΠΊΡƒΡŽ Π΄ΠΈΠ°Π³Π½ΠΎΡΡ‚ΠΈΡ‡Π΅ΡΠΊΡƒΡŽ Ρ†Π΅Π½Π½ΠΎΡΡ‚ΡŒ Π² диагностикС КоАо, ΠΎΠ΄Π½Π°ΠΊΠΎ Π²Π²ΠΈΠ΄Ρƒ ΠΎΠ³Ρ€Π°Π½ΠΈΡ‡Π΅Π½ΠΈΠΉ Π² Π²ΠΈΠ·ΡƒΠ°Π»ΠΈΠ·Π°Ρ†ΠΈΠΈ всСх ΠΎΡ‚Π΄Π΅Π»ΠΎΠ² Π΄ΡƒΠ³ΠΈ Π°ΠΎΡ€Ρ‚Ρ‹ ΠΈ выявлСния ΡΠΎΠΏΡƒΡ‚ΡΡ‚Π²ΡƒΡŽΡ‰ΠΈΡ… ΡΠΊΡΡ‚Ρ€Π°ΠΊΠ°Ρ€Π΄ΠΈΠ°Π»ΡŒΠ½Ρ‹Ρ… Π°Π½ΠΎΠΌΠ°Π»ΠΈΠΉ Π½Π΅ ΠΌΠΎΠΆΠ΅Ρ‚ Π±Ρ‹Ρ‚ΡŒ ΠΎΠΊΠΎΠ½Ρ‡Π°Ρ‚Π΅Π»ΡŒΠ½Ρ‹ΠΌ ΠΏΡ€ΠΈ ΠΏΠ»Π°Π½ΠΈΡ€ΠΎΠ²Π°Π½ΠΈΠΈ ΠΊΠΎΡ€Ρ€Π΅ΠΊΡ†ΠΈΠΈ КоАо Ρƒ ΠΌΠ°Π»Π΅Π½ΡŒΠΊΠΈΡ… Π΄Π΅Ρ‚Π΅ΠΉ. КВ ΠΈ МРВ сСрдца Π½Π°Ρ€Π°Π²Π½Π΅ с Π­Ρ…ΠΎΠšΠ“ ΡΠ²Π»ΡΡŽΡ‚ΡΡ эффСктивными ΠΌΠ΅Ρ‚ΠΎΠ΄ΠΈΠΊΠ°ΠΌΠΈ Π² диагностикС локального суТСния Π°ΠΎΡ€Ρ‚Ρ‹, ΠΎΠ΄Π½Π°ΠΊΠΎ Π² ΠΎΡ†Π΅Π½ΠΊΠ΅ ΡΠΊΡΡ‚Ρ€Π°ΠΊΠ°Ρ€Π΄ΠΈΠ°Π»ΡŒΠ½Ρ‹Ρ… Π°Π½ΠΎΠΌΠ°Π»ΠΈΠΉ ΠΎΠ΄ΠΈΠ½Π°ΠΊΠΎΠ²ΠΎ ΠΏΠΎΠΊΠ°Π·Ρ‹Π²Π°ΡŽΡ‚ достовСрно Π±ΠΎΠ»Π΅Π΅ Ρ‚ΠΎΡ‡Π½Ρ‹ΠΉ Ρ€Π΅Π·ΡƒΠ»ΡŒΡ‚Π°Ρ‚.ΠŸΡ€ΠΎΠ²Π΅Π΄Π΅Π½ΠΈΠ΅ МРВ сСрдца Ρƒ Π΄Π΅Ρ‚Π΅ΠΉ Π΄ΠΎ Π³ΠΎΠ΄Π° ΠΈ младшСй возрастной Π³Ρ€ΡƒΠΏΠΏΡ‹ сопряТСно с тСхничСскими слоТностями ΠΈ Π½Π΅ΠΎΠ±Ρ…ΠΎΠ΄ΠΈΠΌΠΎΡΡ‚ΡŒΡŽ Π±ΠΎΠ»Π΅Π΅ Π΄Π»ΠΈΡ‚Π΅Π»ΡŒΠ½ΠΎΠ³ΠΎ прСбывания Π² Π½Π°Ρ€ΠΊΠΎΠ·Π΅. Учитывая отсутствиС Π΄ΠΎΠΏΠΎΠ»Π½ΠΈΡ‚Π΅Π»ΡŒΠ½ΠΎΠΉ диагностичСски Π·Π½Π°Ρ‡ΠΈΠΌΠΎΠΉ ΠΈΠ½Ρ„ΠΎΡ€ΠΌΠ°Ρ†ΠΈΠΈ Π² сравнСнии с КВ сСрдца, ΠΊΠ°Ρ€Π΄ΠΈΠΎ-МРВ Π½Π΅ являСтся ΠΌΠ΅Ρ‚ΠΎΠ΄ΠΎΠΌ Π²Ρ‹Π±ΠΎΡ€Π° Π² ΠΏΠ΅Ρ€Π²ΠΈΡ‡Π½ΠΎΠΉ диагностикС ΠΈ ΠΏΡ€Π΅Π΄ΠΎΠΏΠ΅Ρ€Π°Ρ†ΠΈΠΎΠ½Π½ΠΎΠΌ ΠΏΠ»Π°Π½ΠΈΡ€ΠΎΠ²Π°Π½ΠΈΠΈ ΠΊΠΎΡ€Ρ€Π΅ΠΊΡ†ΠΈΠΈ КоАо Ρƒ Π΄Π΅Ρ‚Π΅ΠΉ Π΄ΠΎ Π³ΠΎΠ΄Π° ΠΈ младшСй возрастной Π³Ρ€ΡƒΠΏΠΏΡ‹, Ρ‚Ρ€Π΅Π±ΡƒΡŽΡ‰ΠΈΡ… примСнСния анСстСзиологичСского пособия Π½Π° врСмя сканирования

    ΠœΠ°Π³Π½ΠΈΡ‚Π½ΠΎ-рСзонансная томография с отсрочСнным контрастированиСм ΠΏΡ€ΠΈ фибрилляции прСдсСрдий: ΠΏΠ΅Ρ€Π²Ρ‹Π΅ достиТСния ΠΈ пСрспСктивы

    Get PDF
    Current paper reviews new opportunities in none invasiveΒ evaluationΒ  of the left atrial fibrosis in atrial fibrillation usingΒ late gadoliniumΒ  enhancement magnetic resonance imaging.Β The first use of thisΒ  technology in clinical practice is discussed.Β In a group of prospectiveΒ  studies it has been shown thatΒ structural atrial remodeling canΒ  influence the clinical courseΒ of atrial fibrillation and the efficiency ofΒ  arrhythmia treatment.Β Several groups of national and EuropeanΒ  experts in morphologyΒ and MRI studies in a consensus suggestΒ  introductionΒ of a new term fibrous atrial cardiomyopathy or fibrousΒ  cardiomyopathy of atrii, representing the structural and functional pathology of atrii, of clinical value in atrial fibrillation. These dataΒ  make evidence for possibly wide noninvasive MRI studies ofΒ  cardiovascular out-patients in order to make obvious the structure of atrial myocardium and atrial anatomy as a whole. Progress in MRI technologies of heart studies provides the possibility of imaging ofΒ  thin atrial myocardium both in patients with primarily documentedΒ  atrial fibrillation and in persons after interventional treatment of the arrhythmia. There are reasons to expect that LGE MRI dataΒ  regarding atrial structure in atrial fibrillation are in a position toΒ  provide in a nearest future the improvement of management of such patients.Π’ ΡΡ‚Π°Ρ‚ΡŒΠ΅ рассмотрСны возмоТности Π½Π΅ΠΈΠ½Π²Π°Π·ΠΈΠ²Π½ΠΎΠΉΒ ΠΎΡ†Π΅Π½ΠΊΠΈ Ρ„ΠΈΠ±Ρ€ΠΎΠ·Π° Π»Π΅Π²ΠΎΠ³ΠΎ прСдсСрдия ΠΏΡ€ΠΈΒ  фибрилляции прСдсСрдий ΠΏΡ€ΠΈ ΠΏΠΎΠΌΠΎΡ‰ΠΈ ΠΌΠ°Π³Π½ΠΈΡ‚Π½ΠΎ-рСзонансной Ρ‚ΠΎΠΌΠΎΠ³Ρ€Π°Ρ„ΠΈΠΈ (МРВ) с  отсрочСнным контрастированиСм ΠΈ ΠΏΠ΅Ρ€Π²Ρ‹ΠΉ ΠΎΠΏΡ‹Ρ‚ примСнСния этой Ρ‚Π΅Ρ…Π½ΠΎΠ»ΠΎΠ³ΠΈΠΈ Π² клиничСской практикС.Β Π’ рядС проспСктивных исслСдований ΠΏΠΎΠΊΠ°Π·Π°Π½ΠΎ, Ρ‡Ρ‚ΠΎΒ Π²Ρ‹Ρ€Π°ΠΆΠ΅Π½Π½ΠΎΡΡ‚ΡŒΒ  пораТСния прСдсСрдного ΠΌΠΈΠΎΠΊΠ°Ρ€Π΄Π°Β ΠΌΠΎΠΆΠ΅Ρ‚ Π²Π»ΠΈΡΡ‚ΡŒ Π½Π° клиничСскоС Ρ‚Π΅Ρ‡Π΅Π½ΠΈΠ΅ Π°Ρ€ΠΈΡ‚ΠΌΠΈΠΈ ΠΈ Ρ€Π΅Π·ΡƒΠ»ΡŒΡ‚Π°Ρ‚Ρ‹ Π΅Π΅ лСчСния. Ряд отСчСствСнных ΠΈ СвропСйских экспСртов-ΠΌΠΎΡ€Ρ„ΠΎΠ»ΠΎΠ³ΠΎΠ² ΠΈΒ  спСциалистов МРВ Π² совмСстном консСнсусС ΠΏΡ€Π΅Π΄Π»Π°Π³Π°ΡŽΡ‚ ввСсти Ρ‚Π΅Ρ€ΠΌΠΈΠ½ β€œΡ„ΠΈΠ±Ρ€ΠΎΠ·Π½Π°ΡΒ ΠΊΠ°Ρ€Π΄ΠΈΠΎΠΌΠΈΠΎΠΏΠ°Ρ‚ΠΈΡ прСдсСрдий”, ΠΎΡ‚Ρ€Π°ΠΆΠ°ΡŽΡ‰ΠΈΠΉ структурно-Ρ„ΡƒΠ½ΠΊΡ†ΠΈΠΎΠ½Π°Π»ΡŒΠ½ΡƒΡŽΒ  ΠΏΠ°Ρ‚ΠΎΠ»ΠΎΠ³ΠΈΡŽ прСдсСрдий, ΠΈΠΌΠ΅ΡŽΡ‰ΡƒΡŽΒ ΠΊΠ»ΠΈΠ½ΠΈΡ‡Π΅ΡΠΊΡƒΡŽ Π·Π½Π°Ρ‡ΠΈΠΌΠΎΡΡ‚ΡŒ ΠΏΡ€ΠΈ фибрилляции прСдсСрдий.Β  Π­Ρ‚ΠΈ Π΄Π°Π½Π½Ρ‹Π΅ ΠΎΠ±ΠΎΡΠ½ΠΎΠ²Ρ‹Π²Π°ΡŽΡ‚ ΠΏΠΎΡ‚Ρ€Π΅Π±Π½ΠΎΡΡ‚ΡŒ Π² Π½Π΅ΠΈΠ½Π²Π°Π·ΠΈΠ²Π½ΠΎΠΌ обслСдовании ΡˆΠΈΡ€ΠΎΠΊΠΎΠ³ΠΎ ΠΊΡ€ΡƒΠ³Π°Β  кардиологичСских ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚ΠΎΠ² с Ρ†Π΅Π»ΡŒΡŽ ΠΎΡ†Π΅Π½ΠΊΠΈ структуры прСдсСрдного миокарда.Β Π‘ΠΎΠ²Π΅Ρ€ΡˆΠ΅Π½ΡΡ‚Π²ΠΎΠ²Π°Π½ΠΈΠ΅ Ρ‚Π΅Ρ…Π½ΠΎΠ»ΠΎΠ³ΠΈΠΈ МРВ сСрдца с контрастированиСм  позволяСт Π²ΠΈΠ·ΡƒΠ°Π»ΠΈΠ·ΠΈΡ€ΠΎΠ²Π°Ρ‚ΡŒ тонкий прСдсСрдный ΠΌΠΈΠΎΠΊΠ°Ρ€Π΄ ΠΊΠ°ΠΊ Ρƒ ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚ΠΎΠ² с Π²ΠΏΠ΅Ρ€Π²Ρ‹Π΅ выявлСнной ΠΌΠ΅Ρ€Ρ†Π°Ρ‚Π΅Π»ΡŒΠ½ΠΎΠΉ Π°Ρ€ΠΈΡ‚ΠΌΠΈΠ΅ΠΉ, Ρ‚Π°ΠΊ ΠΈ Ρƒ Π»ΠΈΡ†, ΠΏΠ΅Ρ€Π΅Π½Π΅ΡΡˆΠΈΡ… ΠΈΠ½Ρ‚Π΅Ρ€Π²Π΅Π½Ρ†ΠΈΠΎΠ½Π½Ρ‹Π΅ Π²ΠΌΠ΅ΡˆΠ°Ρ‚Π΅Π»ΡŒΡΡ‚Π²Π°.Β Π’ настоящСС врСмя Π΅ΡΡ‚ΡŒ всС основания ΠΏΠΎΠ»Π°Π³Π°Ρ‚ΡŒ, Ρ‡Ρ‚ΠΎΒ ΠœΠ Π’-Π΄Π°Π½Π½Ρ‹Π΅ ΠΎΒ  структурС прСдсСрдий ΠΏΡ€ΠΈ фибрилляции прСдсСрдий Π² блиТайшСй пСрспСктивС ΠΎΠ±Π΅ΡΠΏΠ΅Ρ‡Π°Ρ‚Β ΡΠΎΠ²Π΅Ρ€ΡˆΠ΅Π½ΡΡ‚Π²ΠΎΠ²Π°Π½ΠΈΠ΅ Ρ‚Π°ΠΊΡ‚ΠΈΠΊΠΈ вСдСния Ρ‚Π°ΠΊΠΈΡ… ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚ΠΎΠ²

    Methodology for knowledge portals development: background, foundations, experience of application, problems and prospects

    Get PDF
    The paper discusses an experience of using the methodology for the development of knowledge portals which provide systematization and integration of scientific and engineering knowledge and information resources as well as the content-based access to them. To provide a sufficiently complete and consistent representation of knowledge and information resources, their systematization and integration are performed on the basis of ontology. The suggested methodology has been successfully applied to the development of knowledge Internet portals on archaeology, computational linguistics, strength of materials and Antarctic data

    ΠžΠŸΠ Π•Π”Π•Π›Π•ΠΠ˜Π• Π‘ΠžΠ”Π•Π Π–ΠΠΠ˜Π― Π–Π˜Π Π Π’ ΠŸΠ•Π§Π•ΠΠ˜ Π£ ΠŸΠΠ¦Π˜Π•ΠΠ’ΠžΠ’ Π‘ Π–Π˜Π ΠžΠ’Π«Πœ Π“Π•ΠŸΠΠ’ΠžΠ—ΠžΠœ И Π‘Π’Π•ΠΠ’ΠžΠ“Π•ΠŸΠΠ’Π˜Π’ΠžΠœ ΠœΠ•Π’ΠžΠ”ΠžΠœ ΠŸΠ ΠžΠ’ΠžΠΠΠžΠ™ МР-Π‘ΠŸΠ•ΠšΠ’Π ΠžΠ‘ΠšΠžΠŸΠ˜Π˜

    Get PDF
    Aim. Evaluation of proton MR spectroscopy in the diagnostics of non-alcoholic fatty liver disease.Materials and methods. 70 patients (40 men, 30 women) with non-alcoholic fatty liver disease were included in the study. Average age of patients was 42 Β± 11 years. All patients were divided in two groups. The first group included patients with liver steΠ°thosis (n = 37). Patients with steatohepatitis detected by clinical data formed the second group (n = 33). All patients underwent MR spectroscopy for liver fat content evaluation in two time points (prescreening and after 6 months treatment).Results. MR spectroscopy showed fat content in patients with liver steatosis in the range from 7.5% to 58.4%, the median was 22.4% (lower and upper quartiles were 14.9% and 28.7%). After 6 months the liver fat content significantly decreased up to 1.5–43.7%, the median was 13.5% (the lower and upper quartiles were 5.54% and 18.9%). In patients with steatohepatitis the fat content calculated by MR spectroscopy ranged from 10.5% to 60%, the median was 28.8% (the lower and upper quartiles were 16.5% and 31.2%). There was no significant difference in fat content in this group after 6 months therapy (the median was 26.7%, the lower and upper quartiles were 14.2% and 28.7%, p = 0.22).Conclusion. Proton MR spectroscopy can be successfully used in patients with non-alcoholic fatty liver disease for liver fat content quantification in steatosis and steatohepatitis. MR spectroscopy can be discussed as a non-invasive biopsy alternative for dynamic evaluation during treatment.ЦСль исслСдования: ΠΎΠΏΡ€Π΅Π΄Π΅Π»Π΅Π½ΠΈΠ΅ возмоТности использования ΠΏΡ€ΠΎΡ‚ΠΎΠ½Π½ΠΎΠΉ МР-спСктроскопии Π² диагностикС нСалкогольной ΠΆΠΈΡ€ΠΎΠ²ΠΎΠΉ Π±ΠΎΠ»Π΅Π·Π½ΠΈ ΠΏΠ΅Ρ‡Π΅Π½ΠΈ(ΠΠΠ–Π‘ΠŸ).ΠœΠ°Ρ‚Π΅Ρ€ΠΈΠ°Π» ΠΈ ΠΌΠ΅Ρ‚ΠΎΠ΄Ρ‹. Π’ исслСдованиС Π±Ρ‹Π»ΠΎ Π²ΠΊΠ»ΡŽΡ‡Π΅Π½ΠΎ 70 ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚ΠΎΠ² (40 ΠΌΡƒΠΆΡ‡ΠΈΠ½, 30 ΠΆΠ΅Π½Ρ‰ΠΈΠ½) с ΠΠΠ–Π‘ΠŸ, срСдний возраст ΠΊΠΎΡ‚ΠΎΡ€Ρ‹Ρ… составил 42 Β± 11 Π»Π΅Ρ‚. ΠŸΠ°Ρ†ΠΈΠ΅Π½Ρ‚Ρ‹ Π±Ρ‹Π»ΠΈ Ρ€Π°Π·Π΄Π΅Π»Π΅Π½Ρ‹ Π½Π° 2 Π³Ρ€ΡƒΠΏΠΏΡ‹. 1-я Π³Ρ€ΡƒΠΏΠΏΠ° Π²ΠΊΠ»ΡŽΡ‡Π°Π»Π° Π±ΠΎΠ»ΡŒΠ½Ρ‹Ρ… со стСатозом ΠΏΠ΅Ρ‡Π΅Π½ΠΈ (37 Ρ‡Π΅Π»ΠΎΠ²Π΅ΠΊ). Π’ΠΎ 2-ю Π³Ρ€ΡƒΠΏΠΏΡƒ ΠΎΡ‚Π±ΠΈΡ€Π°Π»ΠΈΡΡŒ ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚Ρ‹ со стСатогСпатитом, выявлСнным ΠΏΠΎ Π΄Π°Π½Π½Ρ‹ΠΌ клиничСских исслСдований (33 ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚Π°). ВсСм ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚Π°ΠΌ Π²Ρ‹ΠΏΠΎΠ»Π½ΡΠ»Π°ΡΡŒ МР-спСктроскопия для опрСдСлСния содСрТания ΠΆΠΈΡ€Π° Π² ΠΏΠ΅Ρ‡Π΅Π½ΠΈ Π² Π΄Π²ΡƒΡ… Ρ‚ΠΎΡ‡ΠΊΠ°Ρ…: ΠΏΠ΅Ρ€Π΅Π΄ Π²ΠΊΠ»ΡŽΡ‡Π΅Π½ΠΈΠ΅ΠΌ Π² исслСдованиС ΠΈ спустя 6 мСс Π½Π° Ρ„ΠΎΠ½Π΅ лСчСния.Π Π΅Π·ΡƒΠ»ΡŒΡ‚Π°Ρ‚Ρ‹. Π’ 1-ΠΉ Π³Ρ€ΡƒΠΏΠΏΠ΅ ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚ΠΎΠ² со стСатозом ΠΏΠ΅Ρ‡Π΅Π½ΠΈ содСрТаниС ΠΆΠΈΡ€Π° ΠΏΠΎ Π΄Π°Π½Π½Ρ‹ΠΌ МР-спСктроскопии Π½Π°Ρ…ΠΎΠ΄ΠΈΠ»ΠΎΡΡŒ Π² ΠΏΡ€Π΅Π΄Π΅Π»Π°Ρ… ΠΎΡ‚ 7,5 Π΄ΠΎ 58,4%, ΠΌΠ΅Π΄ΠΈΠ°Π½Π° составила 22,4%, ниТняя ΠΈ вСрхняя ΠΊΠ²Π°Ρ€Ρ‚ΠΈΠ»ΠΈ – 14,9 ΠΈ 28,7%. ΠŸΡ€ΠΈ рСгистрации спСктров спустя 6 мСс концСнтрация ΠΆΠΈΡ€Π° Π² ΠΏΠ΅Ρ‡Π΅Π½ΠΈ Π·Π½Π°Ρ‡ΠΈΠΌΠΎ снизилась, составляла ΠΎΡ‚ 1,5 Π΄ΠΎ 43,7%, ΠΌΠ΅Π΄ΠΈΠ°Π½Π° – 13,5%, ниТняя ΠΈ вСрхняя ΠΊΠ²Π°Ρ€Ρ‚ΠΈΠ»ΠΈ – 5,54 ΠΈ 18,9% (Ρ€ = 0,015). Π’ΠΎ 2-ΠΉ Π³Ρ€ΡƒΠΏΠΏΠ΅ ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚ΠΎΠ² со стСатогСпатитом содСрТаниС ΠΆΠΈΡ€Π° ΠΏΠΎ Ρ€Π΅Π·ΡƒΠ»ΡŒΡ‚Π°Ρ‚Π°ΠΌ МР-спСктроскопии составило ΠΎΡ‚ 10,5 Π΄ΠΎ 60%, ΠΌΠ΅Π΄ΠΈΠ°Π½Π° – 28,8%, ниТняя ΠΈ вСрхняя ΠΊΠ²Π°Ρ€Ρ‚ΠΈΠ»ΠΈ – 16,5 ΠΈ 31,2%. ΠŸΡ€ΠΈ ΠΏΠΎΠ²Ρ‚ΠΎΡ€Π½ΠΎΠΌ обслСдовании Ρ‡Π΅Ρ€Π΅Π· 6 мСс лСчСния содСрТаниС ΠΆΠΈΡ€Π° Π² ΠΏΠ΅Ρ‡Π΅Π½ΠΈ Ρƒ ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚ΠΎΠ² со стСатогСпатитом достовСрно Π½Π΅ измСнилось: ΠΌΠ΅Π΄ΠΈΠ°Π½Π° 26,7%, ниТняя ΠΈ вСрхняя ΠΊΠ²Π°Ρ€Ρ‚ΠΈΠ»ΠΈ 14,2 ΠΈ 28,7%(Ρ€ = 0,22).Π—Π°ΠΊΠ»ΡŽΡ‡Π΅Π½ΠΈΠ΅. ΠŸΡ€ΠΎΡ‚ΠΎΠ½Π½Π°Ρ МР-спСктроскопия ΠΌΠΎΠΆΠ΅Ρ‚ ΡƒΡΠΏΠ΅ΡˆΠ½ΠΎ ΠΏΡ€ΠΈΠΌΠ΅Π½ΡΡ‚ΡŒΡΡ Ρƒ ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚ΠΎΠ² с ΠΠΠ–Π‘ΠŸ для количСствСнной ΠΎΡ†Π΅Π½ΠΊΠΈ содСрТания ΠΆΠΈΡ€Π° Π² ΠΏΠ΅Ρ‡Π΅Π½ΠΈ ΠΏΡ€ΠΈ стСатозС ΠΈ стСатогСпатитС. Благодаря своСй нСинвазивности МР-спСктроскопия ΠΌΠΎΠΆΠ΅Ρ‚ Ρ€Π°ΡΡΠΌΠ°Ρ‚Ρ€ΠΈΠ²Π°Ρ‚ΡŒΡΡ ΠΊΠ°ΠΊ Π°Π»ΡŒΡ‚Π΅Ρ€Π½Π°Ρ‚ΠΈΠ²Π° биопсии ΠΏΡ€ΠΈ нСобходимости ΠΏΠΎΠ²Ρ‚ΠΎΡ€Π½Ρ‹Ρ… исслСдований для ΠΎΡ†Π΅Π½ΠΊΠΈ Π΄ΠΈΠ½Π°ΠΌΠΈΠΊΠΈ ΠΈΠ·ΠΌΠ΅Π½Π΅Π½ΠΈΠΉ Π½Π° Ρ„ΠΎΠ½Π΅ лСчСния

    Ultrasound examination with contrast in the diagnosis of inflammatory bowel disease. The results of the pilot study

    Get PDF
    Aim. Assessment of diagnostic significance of informativeness and security of ultrasonography with contrast enhancement drug SonoVue in the diagnosis of Crohn's disease (CD) and ulcerative colitis (UC). Materials and methods. The pilot conducted a prospective study which involved 15 patients with inflammatory bowel disease (IBD). All patients gave written consent to participate in the study and processing of personal data. The study included adult patients with an established diagnosis of UC and CD, with proven clinical activity of the disease. Activity was evaluated based on clinical and laboratory data on the scale of best (CDAI >150) for patients with CD and on a scale of Trulove-Witts (2-3 stage) and the Mayo index (DAI) for patients with UC. All the patients underwent colonoscopy with biopsy, ultrasound examination of abdominal cavity organs with the study of the vascularization of the intestinal wall (color Doppler, power Doppler, contrast study). Results. The use of contrast showed additional features in the instrumental evaluation of activity of inflammatory process, identification of complications and assessment of prognosis. Conclusion. The results of ultrasound of the bowel with contrast can be used to assess the activity and stage of disease in patients with UC or CD

    Sequelae of COVID-19 at long-term follow-up after hospitalization

    Get PDF
    Aim. To assess long-term sequelae of COVID-19 in hospitalized patients at 3 to 7 months after discharge.Material and Methods. The whole of 700 patients hospitalized to the temporary COVID-19 treatment center hosted by the FSBI β€œNational Medical Research Center of Cardiology” of the Ministry of Health of Russia from April to June 2020 were invited to participate in a follow-up study. At 3-7 months after the index hospitalization, patients or their proxies were contacted via telephone in order to obtain information on their vital status, cardiovascular and other conditions or their complications, and new hospitalizations. In addition, patients were invited to an outpatient visit under the "COVID-19-follow-up" program, encompassing physical examination and a comprehensive battery of laboratory and instrumental tests, including spirometry, chest computed tomography (CT) and the six minute walk test (6MWT). Further, dyspnea was assessed using the mMRC (Modified Medical Research Council) Dyspnea Scale.Β Results: We were able to contact 87.4% (612/700) of patients or their proxies. At follow-up, 4.4% (27) patients died, of which 96.3% (26) had cardiovascular diseases (CVD). A total of 213 patients aged 19 to 94 years old (mean age 56.8Β±12.5, median 57 years [49.0; 64.0]; men, 55.4%) agreed come for an outpatient visit and to participate in the β€œCOVID-19-follow-up” program. Since discharge, 8% (17) of patients required new hospitalizations, and more than a half of these patients (58.8%; 10/17) had CVD-related hospitalizations. A total of 8.4% (18) patients experienced worsening of hypertension, 9 (4.2%) patients had newly diagnosed hypertension, 2 (0.9%) – coronary artery disease patients experienced new/recurrent angina symptoms. 4 (1.9%) patients had newly diagnosed coronary artery disease, and one patient had an ischemic stroke. At the outpatient visit, 114 (53.5%) patients had some symptoms, most frequently, shortness of breath (33%), fatigue (27.4%), chest pain (11.3%), and abnormal heartbeats (8.5%). Based on the mMRC Scale, 59% of patients had dyspnea of varying severity. Most patients had a normal vital capacity (VC), which was moderately reduced in 3.3% and severely reduced in 0.5% of patients. Chest CT scans were obtained in 78 (36.6%) patients, whose worst lung damage scores during hospitalization were CT3 or CT4. One in ten patients (10.8%) with severe lung damage during acute infection had persisting ground glass opacities, 35.9% developed fibrotic changes, 79.6% of patients had linear or fine focal opacities. According to the 6MWT data, 12.3% of patients walked less than 70% of the predicted distance, 67% walked 71 to 99% of the predicted distance, and 20.7% of patients were able to walk 100% of their predicted distance.Conclusion. These data suggest long-term negative sequelae of COVID-19 in more than half of hospitalized patients

    Prerequisites for the creation of an atlas of postcovid inflammation as a way of personalized pharmacotherapy, as well as predicting and preventing organ and systemic dysfunctions

    Get PDF
    SARS-CoV-2 is a novel coronavirus that has been identified as the cause of the 2019 coronavirus infection (COVID-19), which originated at Wuhan city of PRC in late 2019 and widespread worldwide. As the number of patients recovering from COVID-19 continue to grow, it’s very important to understand what health issues they may keep experiencing. COVID-19 is now recognized as an infectious disease that can cause multiple organ diseases of various localization. It is against this background that a new term was introduced: post-acute post-COVID-19 syndrome characterized by several persistent symptoms inherent in the acute phase of the disease, as well as the occurrence of delayed and (or) long-term complications beyond 4 weeks from the onset of the disease. The work reflected in this article revealed a portrait of a patient with post-COVID-19 syndrome, the most common complications of this period, as well as the mechanisms of their development and the resulting metabolic, cellular, tissue disorders leading to the tissue and organ dysfunctions. A comprehensive biochemical and immunological screening was carried out using the example of three clinical cases to identify the most significant disorders in these patients and to correlate with their clinical status over time. In point of fact, such patients were diagnosed with vascular dysfunction factors (development of endothelial dysfunction), metabolic dysfunction factors (metabolic acidosis, mitochondrial dysfunction, carbohydrate metabolism disorder, insulin resistance, altered branched-chain and aromatic amino acid metabolism), neurological disorder factors (neurotoxicity of the resulting metabolites), immunological disorder factors (decreased efficiency of detoxification systems, secondary immunodeficiency, risk of secondary bacterial infection)

    ΠΠ°Ρ€ΡƒΡˆΠ΅Π½ΠΈΡ синхронизации кровообращСния ΠΈ дыхания ΠΏΡ€ΠΈ гипСркапничСской Π΄Ρ‹Ρ…Π°Ρ‚Π΅Π»ΡŒΠ½ΠΎΠΉ ΠΏΡ€ΠΎΠ±Π΅ ΠΈ ΡƒΠΌΠ΅Ρ€Π΅Π½Π½Ρ‹Ρ… физичСских Π½Π°Π³Ρ€ΡƒΠ·ΠΊΠ°Ρ… Ρƒ ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚ΠΎΠ² c ΠΏΡƒΠ»ΡŒΠΌΠΎΠ½ΠΎΠ»ΠΎΠ³ΠΈΡ‡Π΅ΡΠΊΠΎΠΉ ΠΏΠ°Ρ‚ΠΎΠ»ΠΎΠ³ΠΈΠ΅ΠΉ

    Get PDF
    Relevance.The comprehensive assessment of cardiorespiratory coupling (CRC) for the diagnosis of functional adaptation in pulmonological patients is presented.The objective of the study was to test the complex criteria of CRC for objective differential diagnosis of individual adaptive reactions of pulmonological patients.Methods and materials. 30 volunteers without verified pathology and 31 patients with restrictive and obstructive disorders were examined. All subjects underwent physical examination with traditional routine method using spiroarteriocardiorhythmography (SACR) at rest and during performing functional tests with hypercapnia and moderate physical exercise.Results. We proposed the methodology of integrated assessment of multicomponent system of CRC, which increases the diagnostic precision of SACR in the tasks of predicting the adaptive defects of the organism at different pulmonary syndromes.Conclusion. Breathing with a fixed frequency normalizes the regulation of CRC, both in healthy and pulmonological patients. Moderate physical activity (80 W) modifies the indicators of CRC in pulmonological patients in comparison with the control group statistically due to disorders of the heart rate and circulation. During moderate physical activity, stroke volume (SV) statistically decreases in patients differently: SV were significantly lower in the group with obstructive disorders than in the group with non-obstructive disorders.Β Π’Π²Π΅Π΄Π΅Π½ΠΈΠ΅. ΠŸΡ€Π΅Π΄Π»ΠΎΠΆΠ΅Π½Π° комплСксная ΠΎΡ†Π΅Π½ΠΊΠ° сСрдСчно-сосудисто-Π΄Ρ‹Ρ…Π°Ρ‚Π΅Π»ΡŒΠ½ΠΎΠΉ синхронизации (Π‘Π‘Π”Π‘) Ρƒ Π±ΠΎΠ»ΡŒΠ½Ρ‹Ρ… с ΠΏΡƒΠ»ΡŒΠΌΠΎΠ½ΠΎΠ»ΠΎΠ³ΠΈΡ‡Π΅ΡΠΊΠΎΠΉ ΠΏΠ°Ρ‚ΠΎΠ»ΠΎΠ³ΠΈΠ΅ΠΉ.ЦСль исслСдования β€” апробация комплСксных ΠΊΡ€ΠΈΡ‚Π΅Ρ€ΠΈΠ΅Π² Π‘Π‘Π”Π‘ для ΠΎΠ±ΡŠΠ΅ΠΊΡ‚ΠΈΠ²Π½ΠΎΠΉ Π΄ΠΈΡ„Ρ„Π΅Ρ€Π΅Π½Ρ†ΠΈΠ°Π»ΡŒΠ½ΠΎΠΉ диагностики ΠΈΠ½Π΄ΠΈΠ²ΠΈΠ΄ΡƒΠ°Π»ΡŒΠ½Ρ‹Ρ… Ρ„ΡƒΠ½ΠΊΡ†ΠΈΠΎΠ½Π°Π»ΡŒΠ½Ρ‹Ρ… Ρ€Π΅Π°ΠΊΡ†ΠΈΠΉ ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚ΠΎΠ² с ΠΏΡƒΠ»ΡŒΠΌΠΎΠ½ΠΎΠ»ΠΎΠ³ΠΈΡ‡Π΅ΡΠΊΠΎΠΉ ΠΏΠ°Ρ‚ΠΎΠ»ΠΎΠ³ΠΈΠ΅ΠΉ.ΠœΠ΅Ρ‚ΠΎΠ΄Ρ‹ ΠΈ ΠΌΠ°Ρ‚Π΅Ρ€ΠΈΠ°Π»Ρ‹. ОбслСдовали 30 Π΄ΠΎΠ±Ρ€ΠΎΠ²ΠΎΠ»ΡŒΡ†Π΅Π² Π±Π΅Π· Π²Π΅Ρ€ΠΈΡ„ΠΈΡ†ΠΈΡ€ΠΎΠ²Π°Π½Π½ΠΎΠΉ ΠΏΠ°Ρ‚ΠΎΠ»ΠΎΠ³ΠΈΠΈ ΠΈ 31 ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚Π° с обструктивными ΠΈ нСобструктивными Π½Π°Ρ€ΡƒΡˆΠ΅Π½ΠΈΡΠΌΠΈ. ΠŸΡ€ΠΎΠ²ΠΎΠ΄ΠΈΠ»ΠΈ Ρ„ΠΈΠ·ΠΈΠΊΠ°Π»ΡŒΠ½ΠΎΠ΅ обслСдованиС ΠΏΠΎ Ρ‚Ρ€Π°Π΄ΠΈΡ†ΠΈΠΎΠ½Π½ΠΎΠΉ Ρ€ΡƒΡ‚ΠΈΠ½Π½ΠΎΠΉ ΠΌΠ΅Ρ‚ΠΎΠ΄ΠΈΠΊΠ΅ с использованиСм спироартСриокардиоритмографии (БАКР) Π² ΠΏΠΎΠΊΠΎΠ΅ ΠΈ ΠΏΡ€ΠΈ Π²Ρ‹ΠΏΠΎΠ»Π½Π΅Π½ΠΈΠΈ Ρ„ΡƒΠ½ΠΊΡ†ΠΈΠΎΠ½Π°Π»ΡŒΠ½Ρ‹Ρ… ΠΏΡ€ΠΎΠ± с Π³ΠΈΠΏΠ΅Ρ€ΠΊΠ°ΠΏΠ½ΠΈΠ΅ΠΉ ΠΈ ΡƒΠΌΠ΅Ρ€Π΅Π½Π½ΠΎΠΉ физичСской Π½Π°Π³Ρ€ΡƒΠ·ΠΊΠΎΠΉ.Π Π΅Π·ΡƒΠ»ΡŒΡ‚Π°Ρ‚Ρ‹. ΠŸΡ€Π΅Π΄Π»ΠΎΠΆΠ΅Π½Π° мСтодология комплСксной ΠΎΡ†Π΅Π½ΠΊΠΈ ΠΌΠ½ΠΎΠ³ΠΎΠΊΠΎΠΌΠΏΠΎΠ½Π΅Π½Ρ‚Π½ΠΎΠΉ систСмы Π‘Π‘Π”Π‘, которая ΠΏΠΎΠ²Ρ‹ΡˆΠ°Π΅Ρ‚ Π΄ΠΈΠ°Π³Π½ΠΎΡΡ‚ΠΈΡ‡Π΅ΡΠΊΡƒΡŽ ΡΡ„Ρ„Π΅ΠΊΡ‚ΠΈΠ²Π½ΠΎΡΡ‚ΡŒ БАКР Π² Π·Π°Π΄Π°Ρ‡Π°Ρ… прогнозирования Ρ„ΡƒΠ½ΠΊΡ†ΠΈΠΎΠ½Π°Π»ΡŒΠ½ΠΎΠΉ ΡΠΎΡΡ‚ΠΎΡΡ‚Π΅Π»ΡŒΠ½ΠΎΡΡ‚ΠΈ ΠΎΡ€Π³Π°Π½ΠΈΠ·ΠΌΠ° ΠΏΡ€ΠΈ Ρ€Π°Π·Π»ΠΈΡ‡Π½Ρ‹Ρ… ΡΠΈΠ½Π΄Ρ€ΠΎΠΌΠ°Π»ΡŒΠ½Ρ‹Ρ… Π²Π°Ρ€ΠΈΠ°Π½Ρ‚Π°Ρ… ΠΏΡƒΠ»ΡŒΠΌΠΎΠ½ΠΎΠ»ΠΎΠ³ΠΈΡ‡Π΅ΡΠΊΠΎΠΉ ΠΏΠ°Ρ‚ΠΎΠ»ΠΎΠ³ΠΈΠΈ.Π’Ρ‹Π²ΠΎΠ΄Ρ‹. Π”Ρ‹Ρ…Π°Π½ΠΈΠ΅ с фиксированной частотой Π½ΠΎΡ€ΠΌΠ°Π»ΠΈΠ·ΡƒΠ΅Ρ‚ Ρ€Π΅Π³ΡƒΠ»ΡΡ†ΠΈΡŽ Π‘Π‘Π”Π‘, ΠΊΠ°ΠΊ Ρƒ Π·Π΄ΠΎΡ€ΠΎΠ²Ρ‹Ρ…, Ρ‚Π°ΠΊ ΠΈ Ρƒ Π±ΠΎΠ»ΡŒΠ½Ρ‹Ρ… с ΠΏΡƒΠ»ΡŒΠΌΠΎΠ½ΠΎΠ»ΠΎΠ³ΠΈΡ‡Π΅ΡΠΊΠΎΠΉ ΠΏΠ°Ρ‚ΠΎΠ»ΠΎΠ³ΠΈΠ΅ΠΉ. ΠŸΡ€ΠΈ ΡƒΠΌΠ΅Ρ€Π΅Π½Π½ΠΎΠΉ физичСской Π½Π°Π³Ρ€ΡƒΠ·ΠΊΠ΅ (ΠΌΠ΅Π½Π΅Π΅ 80 Π’Ρ‚) ΠΏΠΎΠΊΠ°Π·Π°Ρ‚Π΅Π»ΠΈ Π‘Π‘Π”Π‘ Ρƒ ΠΏΡƒΠ»ΡŒΠΌΠΎΠ½ΠΎΠ»ΠΎΠ³ΠΈΡ‡Π΅ΡΠΊΠΈΡ… Π±ΠΎΠ»ΡŒΠ½Ρ‹Ρ… статистичСски достовСрно ΠΈΠ·ΠΌΠ΅Π½ΡΡŽΡ‚ΡΡ ΠΏΠΎ ΡΡ€Π°Π²Π½Π΅Π½ΠΈΡŽ с ΠΊΠΎΠ½Ρ‚Ρ€ΠΎΠ»ΡŒΠ½ΠΎΠΉ Π³Ρ€ΡƒΠΏΠΏΠΎΠΉ, прСимущСствСнно Π·Π° счСт Π½Π°Ρ€ΡƒΡˆΠ΅Π½ΠΈΡ рСгуляции сСрдСчного Ρ€ΠΈΡ‚ΠΌΠ° ΠΈ кровообращСния. ΠŸΡ€ΠΈ Π²Ρ‹ΠΏΠΎΠ»Π½Π΅Π½ΠΈΠΈ ΠΏΡ€ΠΎΠ±Ρ‹ с ΡƒΠΌΠ΅Ρ€Π΅Π½Π½ΠΎΠΉ физичСской Π½Π°Π³Ρ€ΡƒΠ·ΠΊΠΎΠΉ сниТСниС ΠΏΠΎΠΊΠ°Π·Π°Ρ‚Π΅Π»Π΅ΠΉ Π‘Π‘Π”Π‘ Ρƒ Π±ΠΎΠ»ΡŒΠ½Ρ‹Ρ… статистичСски достовСрно различаСтся ΠΏΠΎ ΡƒΠ΄Π°Ρ€Π½ΠΎΠΌΡƒ ΠΎΠ±ΡŠΠ΅ΠΌΡƒ (УО): Π² Π³Ρ€ΡƒΠΏΠΏΠ΅ с обструктивными Π½Π°Ρ€ΡƒΡˆΠ΅Π½ΠΈΡΠΌΠΈ значСния УО Π±Ρ‹Π»ΠΈ сущСствСнно Π½ΠΈΠΆΠ΅, Ρ‡Π΅ΠΌ Π² Π³Ρ€ΡƒΠΏΠΏΠ΅ Π±Π΅Π· обструктивных Π½Π°Ρ€ΡƒΡˆΠ΅Π½ΠΈΠΉ.
    • …
    corecore